{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:01:30Z","timestamp":1791644490300,"version":"4.3.4"},"reference-count":27,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[1999,3,1]],"date-time":"1999-03-01T00:00:00Z","timestamp":920246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[1999,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Histoplasmosis is an important systemic fungal infection, particularly among immunocompromised individuals, who may develop a progressive disseminated form which is often fatal if it is untreated. In such patients, the detection of antibody responses for both diagnosis and follow-up may be of limited use, whereas the detection of\n            <jats:italic>Histoplasma capsulatum<\/jats:italic>\n            var.\n            <jats:italic>capsulatum<\/jats:italic>\n            antigens may provide a more practical approach. We have recently described an inhibition enzyme-linked immunosorbent assay (ELISA) for the detection in patients\u2019 sera of a 69- to 70-kDa\n            <jats:italic>H. capsulatum<\/jats:italic>\n            var.\n            <jats:italic>capsulatum<\/jats:italic>\n            -specific antigen which appears to be useful in diagnosis. To investigate its potential for the follow-up of histoplasmosis patients during treatment, antigen titers in the sera of 16 patients presenting with different clinical forms of histoplasmosis were monitored at regular intervals for up to 80 weeks. Sera from four of five patients with the acute form of the disease showed rapid falls in antigenemia, becoming antigen negative by week 14 (range, weeks 10 to 16). Sera from four patients with disseminated histoplasmosis showed falls in antigen levels; three of them became antigen negative by week 32; the fourth patient became negative by week 48. In contrast, antigen titers in four of six AIDS patients with the disseminated form of the disease remained positive throughout follow-up. Sera from only one patient who presented with the chronic form of the disease were analyzed, and this individual\u2019s serum became antigen negative by week 9. The inhibition ELISA is shown to be of particular use in the monitoring of non-AIDS patients with the acute and disseminated forms of the disease and may complement existing means of follow-up.\n          <\/jats:p>","DOI":"10.1128\/jcm.37.3.675-680.1999","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T17:43:07Z","timestamp":1577814187000},"page":"675-680","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":32,"title":["Detection of the 70-Kilodalton\n            <i>Histoplasma capsulatum<\/i>\n            Antigen in Serum of Histoplasmosis Patients: Correlation between Antigenemia and Therapy during Follow-Up"],"prefix":"10.1128","volume":"37","author":[{"given":"B. L.","family":"Go\u0301mez","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Corporacio\u0301n para Investigaciones Biolo\u0301gicas, A. A. 73-78,1 and"},{"name":"<!--label omitted: 2-->St. John\u2019s Institute of Dermatology, The Guy\u2019s, King\u2019s College, and St. Thomas\u2019 Hospitals\u2019 Medical and Dental School, Thomas Guy House, Guy\u2019s Hospital, London SE1 9RT, England2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. I.","family":"Figueroa","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->St. John\u2019s Institute of Dermatology, The Guy\u2019s, King\u2019s College, and St. Thomas\u2019 Hospitals\u2019 Medical and Dental School, Thomas Guy House, Guy\u2019s Hospital, London SE1 9RT, England2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. J.","family":"Hamilton","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->St. John\u2019s Institute of Dermatology, The Guy\u2019s, King\u2019s College, and St. Thomas\u2019 Hospitals\u2019 Medical and Dental School, Thomas Guy House, Guy\u2019s Hospital, London SE1 9RT, England2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Diez","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Corporacio\u0301n para Investigaciones Biolo\u0301gicas, A. A. 73-78,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rojas","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Laboratorio Central de Investigaciones, Facultad de Medicina, Universidad de Antioquia,3Medell\u0131\u0301n, Colombia, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tobo\u0301n","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Corporacio\u0301n para Investigaciones Biolo\u0301gicas, A. A. 73-78,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Restrepo","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Corporacio\u0301n para Investigaciones Biolo\u0301gicas, A. A. 73-78,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. J.","family":"Hay","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->St. John\u2019s Institute of Dermatology, The Guy\u2019s, King\u2019s College, and St. Thomas\u2019 Hospitals\u2019 Medical and Dental School, Thomas Guy House, Guy\u2019s Hospital, London SE1 9RT, England2"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0036-46651995000600010"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/22.Supplement_2.S102"},{"key":"e_1_3_2_4_2","unstructured":"Bullock\nW. E. Histoplasma capsulatum Principles and practice of infectious diseases.\nMandell\nG. L.\nBennett\nJ.\nDolin\nR.\n1995\n2340\n2353\nChurchill Livingstone\nNew York N.Y"},{"key":"e_1_3_2_5_2","first-page":"381","article-title":"The Histoplasma capsulatum antigen assay in disseminated histoplasmosis in children","volume":"30","author":"Fotjasek M. F.","year":"1994","unstructured":"Fotjasek M. F. Kleiman M. B. Connolly-Stringfield P. Blair R. Wheat J. The Histoplasma capsulatum antigen assay in disseminated histoplasmosis in children.J. Clin. Microbiol.301994381385","journal-title":"J. Clin. Microbiol."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/21.4.1054"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.35.10.2618-2622.1997"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198107000-00001"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198001000-00001"},{"key":"e_1_3_2_10_2","unstructured":"Hay\nR. J.\nClinical manifestations and management of cryptococcosis in the compromised patient\nFungal infection in the compromised patient.\nWarnock\nD. W.\nRichardson\nM. D.\n1991\n85\n115\nJohn Wiley & Sons Ltd.\nChichester United Kingdom"},{"key":"e_1_3_2_11_2","unstructured":"Kwon-Chung\nK. J.\nBennett\nJ. E.\nHistoplasmosis\nMedical mycology.\nKwon-Chung\nK. J.\nBennett\nJ. E.\n1992\n464\n513\nLea & Febiger\nPhiladelphia Pa"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1086\/513653"},{"key":"e_1_3_2_13_2","first-page":"5","article-title":"Histoplasmosis diseminada en pacientes con SIDA, su evoluci\u00f3n y tratamiento","volume":"14","author":"Negroni R.","year":"1991","unstructured":"Negroni R. Robles A. M. Arechavala A. Taborda A. Histoplasmosis diseminada en pacientes con SIDA, su evoluci\u00f3n y tratamiento.Rev. Arg. Micol.141991512","journal-title":"Rev. Arg. Micol."},{"key":"e_1_3_2_14_2","unstructured":"Palmer\nD. F.\nKaufman\nL.\nKaplan\nW.\nCavallaro\nJ.\nMacroimmunodiffusion test for histoplasmosis\nSerodiagnosis of mycotic diseases.\nBalows\nA.\n1977\n19\n27\nCharles C Thomas Publisher\nSpringfield Ill"},{"key":"e_1_3_2_15_2","unstructured":"Palmer\nD. F.\nKaufman\nL.\nKaplan\nW.\nCavallaro\nJ.\nThe complement fixation test\nSerodiagnosis of mycotic diseases.\nBalows\nA.\n1977\n155\n178\nCharles C Thomas Publisher\nSpringfield Ill"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(20)30577-8"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199611000-00014"},{"key":"e_1_3_2_18_2","first-page":"277","article-title":"Histoplasmosis en el adulto: bases para su diagn\u00f3stico","volume":"22","author":"Tob\u00f3n A. M.","year":"1997","unstructured":"Tob\u00f3n A. M. Franco L. Correa A. L. Bedoya F. Ortega J. Soto M. Arango M. Valencia O. Restrepo A. Histoplasmosis en el adulto: bases para su diagn\u00f3stico.Acta Med. Colomb.221997277284","journal-title":"Acta Med. Colomb."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)80311-8"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01964063"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/19.Supplement_1.S19"},{"key":"e_1_3_2_22_2","first-page":"7","article-title":"Histoplasmosis in the acquired immunodeficiency syndrome","volume":"7","author":"Wheat L. J.","year":"1996","unstructured":"Wheat L. J. Histoplasmosis in the acquired immunodeficiency syndrome.Curr. Top. Med. Mycol.71996718","journal-title":"Curr. Top. Med. Mycol."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-12-936"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(92)90106-L"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/145.6.1421"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198601093140205"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1086\/513647"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/160.4.678"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.37.3.675-680.1999","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.37.3.675-680.1999","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T23:59:53Z","timestamp":1646438393000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.37.3.675-680.1999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,3]]}},"alternative-id":["10.1128\/JCM.37.3.675-680.1999"],"URL":"https:\/\/doi.org\/10.1128\/jcm.37.3.675-680.1999","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,3]]},"assertion":[{"value":"1998-09-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-12-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-03-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}